Looking to list your PhD opportunities? Log in here.
About the Project
Antibiotics make possible the treatment and cure of life-threatening bacterial infections and have added over a decade to the average human lifespan. Unfortunately, the utility of these drugs is being rapidly eroded as pathogenic bacteria evolve to resist their effects; in 2019, antimicrobial resistance (AMR) killed ~1.3 million people worldwide, and this figure is set to rise to 10 million by 2050. To address this problem, it is imperative that new antibiotics are discovered as matter of urgency.
The best-validated source of antibiotics is nature, with most of our existing antibiotic armamentarium deriving from soil microorganisms. However, this source stopped routinely yielding novel compounds decades ago and was largely abandoned in the search for new antibiotics. Viewed through the lens of our current knowledge, this was not because this source had been comprehensively mined – far from it, in fact– but simply that continuing to screen the same types of microorganisms in the same way will not deliver new antibiotics (“if you do what you have always done, you get what you always got”).
Our view is that nature remains far and away the best place to look for new antibiotics, though strategic innovation will be essential to do so effectively. The O’Neill lab is working to systematically address the pit-falls and bottle-necks in natural product antibiotic discovery, identifying new sources/ types of microorganism for testing, creating novel screening tools for improved detection of antibiotics, and evolving approaches that allow rapid assessment of the chemical/ functional novelty and therapeutic potential of these compounds .
The proposed studentship will not only work to establish innovative approaches to antibiotic discovery, but will also deploy these to identify new drug candidates effective against the most problematic types of multi-drug resistant bacteria. Building on exciting recent findings in our lab, this project will utilise ichip technology to recover microorganisms new to science from a variety of sources, and will screen these for antibiotic production using novel tools/ approaches that will be created or evolved over the course of the study. Collectively, this project will rejuvenate and accelerate the discovery of new antibiotics from nature, thereby helping to address the global challenge of AMR and providing the appointed student with cutting-edge, multidisciplinary training in bacteriology, molecular biology and antibiotic discovery.
Please see the O’Neill lab website for more information about what we do, and links to our published work:
https://biologicalsciences.leeds.ac.uk/molecular-and-cellular-biology/staff/119/professor-alex-o-neill
Eligibility:
You should hold a first degree equivalent to at least a UK upper-second class honours degree or a MSc degree in a relevant subject; this project would suit someone with a background in molecular microbiology, biochemistry, drug discovery or closely related areas. Additional experience of conducting research in a multidisciplinary setting is highly desirable. Upon completion of the PhD, the successful candidate will be uniquely equipped for high-demand careers within academia or industry with desirable skills in drug discovery.
Applicants whose first language is not English must provide evidence that their English language is sufficient to meet the specific demands of their study. The Faculty of Biological Sciences minimum requirements in IELTS and TOEFL tests are:
- British Council IELTS - score of 6.0 overall, with no element less than 5.5
- TOEFL iBT - overall score of 87 with the listening and reading element no less than 20, writing element no less than 21 and the speaking element no less than 22.
How to apply:
To apply for this project applicants should complete an online application form and attach the following documentation to support their application.
- a full academic CV
- degree certificate and transcripts of marks
- Evidence that you meet the University's minimum English language requirements (if applicable).
- Evidence of funding
To help us identify that you are applying for this project please ensure you provide the following information on your application form;
- Select PhD in Biological Sciences as your programme of study
- Give the full project title and name the supervisors listed in this advert
References
Mohamad M, Nicholson D, Saha CK, Hauryliuk V, Edwards TA, Atkinson GC, Ranson NA, O'Neill AJ (2022) Sal-type ABC-F proteins: intrinsic and common mediators of pleuromutilin resistance by target protection in staphylococci. Nucleic Acids Research, 50: 2128-2142.
Galarion LH, Mohamad M, Alzeyadi Z, Randall CP, O'Neill AJ (2021). A platform for detecting cross-resistance in antibacterial drug discovery. Journal of Antimicrobial Chemotherapy, 76: 1467-1471
Nass NM, Farooque S, Hind C, Wand ME, Randall CP, Sutton JM, Seipke RF, Rayner C, O'Neill AJ (2017). Revisiting unexploited antibiotics in search of new antibacterial drug candidates: the case of gamma-actinorhodin. Scientific Reports, 7: 17419
How good is research at University of Leeds in Biological Sciences?
Research output data provided by the Research Excellence Framework (REF)
Click here to see the results for all UK universitiesEmail Now
Why not add a message here
The information you submit to University of Leeds will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Leeds, United Kingdom
Check out our other PhDs in United Kingdom
Start a New search with our database of over 4,000 PhDs

PhD suggestions
Based on your current search criteria we thought you might be interested in these.
Broadening the spectrum of antibacterial drugs to tackle multi-drug resistant Gram-negative pathogens
University of Leeds
Towards the development of a novel class of broad-spectrum anti-infective drugs
University of Strathclyde
Formulation and biopharmaceutical characterisation of novel pro-antibiotics for improved oral permeability
University of Bradford